Current diagnostic methods do not always reliably distinguish between chronic inflammation of the pancreas and pancreatic cancer. About one third of all diagnoses are inconclusive. Scientists from the German Cancer Research ...
Sep 20, 2023
0
0
Researchers from Mayo Clinic Comprehensive Cancer Center and Mayo Clinic Center for Individualized Medicine have discovered new genetic markers to identify Lynch syndrome-associated colorectal cancer with high accuracy. Studies ...
Sep 20, 2023
0
0
Skipping genetic counseling before or after taking a remote screening of inherited risk for ovarian or breast cancer does not increase distress, anxiety or depression, according to a study published Sept. 14 in JAMA Oncology.
Sep 19, 2023
0
6
Despite advances in surgery and chemotherapy, survival of people with certain types of ovarian cancer has not significantly changed in decades. That has meant that some ovarian cancer patients go through treatments that don't ...
Aug 3, 2023
0
16
Weight gain in a man's late teens and 20s increases his risk of dying from prostate cancer later in life, research being presented at the European Congress on Obesity (ECO) in Dublin, Ireland (May 17-20), suggests.
May 16, 2023
0
2
In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and Program Leader in the Molecular & Cellular Oncogenesis Program, and team have ...
Feb 6, 2023
0
64
Researchers at The Tisch Cancer Institute uncovered inflammatory markers that may predict which COVID-19 patients are more likely to respond to therapies like the anti-cancer drug pacritinib, according to phase 2 trial results ...
Dec 5, 2022
0
7
My mother recently was diagnosed with diabetes, but due to abdominal pain and other issues, her doctor suspects she might have pancreatic cancer. How is pancreatic cancer diagnosed and what are the symptoms to watch for?
Nov 14, 2022
0
2
Scientists have discovered that cervical cancer can be divided into two distinct molecular subgroups—one far more aggressive than the other—as part of the largest "omics" study of its kind, led by researchers at UCL and ...
Oct 21, 2022
0
53
It may soon be possible to identify Group 4 medulloblastomas—the most common malignant brain tumor in children—from more aggressive Group 3 tumors. Research based on a little-explored part of RNA, which creates proteins, ...
Sep 21, 2022
0
3
